CT
EXAS

Clearstead Trust’s Exact Sciences EXAS Stock Holding History

Clearstead Trust’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-85
Closed -$8.63K – 1005
2025
Q4 		$8.63K Hold
85
– – ﹤0.01% 629
2025
Q3 		$4.65K Hold
85
– – ﹤0.01% 782
2025
Q2 		$4.52K Buy
85
+47
+124% +$2.39K ﹤0.01% 775
2025
Q1 		$1.65K Buy
+38
New +$1.92K ﹤0.01% 788

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Clearstead Trust's EXAS Position: Q1 2026 in Review

Clearstead Trust sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 85 shares — an estimated $8.63K sold.

Clearstead Trust first reported a position in EXAS in Q1 2025 and held it in 4 quarters. The position peaked at $8.63K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Clearstead Trust reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Clearstead Trust sold 85 Exact Sciences shares in Q1 2026, an estimated $8.63K.
  • Clearstead Trust first reported a position in Exact Sciences in Q1 2025 and held it in 4 quarters.
  • Clearstead Trust's Exact Sciences position peaked at $8.63K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Clearstead Trust's 13F filing for Q1 2026, filed 6 May 2026.